Lexapro Launched in Japan Despite Birth Defect Risks

This is Michael Brady Lynch, lead trial attorney at The Michael Brady Lynch Firm.
I always find it baffling that even in the face of overwhelming evidence that a drug causes severe side effects that far outweigh the benefits of treatment, drug companies can push through an approval process with the pressure and influence of aggressive lobbying efforts.
It simply makes no sense to see the use of Lexapro expand into the Japanese market when the strong correlation and association with severe birth defects threatens to explode into a public health nightmare. Japan would have been well served to heed the warning signs evident in the U.S. market before jumping onto the Lexapro bandwagon.
 
About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.